Skip to content

Effects of Craniosacral Therapy on Chronic Neck Pain

Effects of Craniosacral Therapy on Chronic Neck Pain: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01526447
Acronym
CranioS
Enrollment
54
Registered
2012-02-03
Start date
2012-02-29
Completion date
2013-04-30
Last updated
2019-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Pain

Keywords

Neck Pain, Craniosacral Manipulation, Complementary Therapies, Randomized Controlled Trial, Sensory Thresholds, Quality of Life

Brief summary

The purpose of this randomized controlled trial is to determinate the efficacy and safety of Craniosacral Therapy in the treatment of chronic unspecific neck pain.

Detailed description

Craniosacral Therapy (CST) is a variation of osteopathic manipulation with an integrative approach. By soft manual palpation of the craniosacral and fascia system sensory, motor, cognitive, and emotional processes can be influenced. In the prevention and treatment of chronic pain syndromes Craniosacral Therapy is demonstrated to be effective in clinical practice and quite a few scientific trials. But yet there are no randomized controlled studies concerning to chronic neck pain. So the aim of this study is to investigate whether a total of 8 CST units of 45 minutes will be effective in patients suffering from chronic nonspecific neck pain in contrast to sham therapy of the same extent. The prospective study design includes measurement points at baseline, post treatment, and 3 months follow-up.

Interventions

Standardized therapy protocol (according to Upledger): Still point technique, diaphragm release, compression-decompression and lift techniques of the cranial bones, facial balancing in the region of shoulder and pelvis and somato-emotional unwinding

PROCEDURESham Craniosacral Therapy

Standardized sham protocol: Placing hands on various parts of the clothed body for two minutes each time without therapeutic intention

Sponsors

Universität Duisburg-Essen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Chronic unspecific neck pain for at least 3 months * Mean neck pain of moderate intensity (\>/=45mm on VAS) * Therapy-naive subjects

Exclusion criteria

* Specific neck pain due to severe deformity of the spine, prolapse, rheumatic or neurological disorder, trauma, operation or cancer * other severe somatic or psychiatric comorbidity * pregnancy * regular intake of opiates, corticosteroids (\>10mg prednisolon), muscle relaxants or antidepressants * recent invasive or manipulative treatment of the spine * participation in other clinical trials

Design outcomes

Primary

MeasureTime frameDescription
Pain intensityweek 8Pain intensity on a 100mm visual analogue scale (VAS)

Secondary

MeasureTime frameDescription
Pressure pain thresholdweek 8Pressure pain threshold (PPT) measured with an algometer on predefined muscles and the pain maximum
Disabilityweek 8Measured by the Neck Disability Indx (NDI)
Quality of lifeweek 8Measured by the Short-Form Health Survey (SF-12)
Well beingweek 8Measured by the Questionnaire for Assessing Subjective Physical Well-Being (FEW-16)
Anxiety and depressionweek 8Measured by the Hospital Anxiety and Depression Scale (HADS)
Pain intensity in motionweek 8Pain intensity induced by flexion, extension, lateral flexion and rotation of the head on a 100mm visual analogue scale (VAS)
Pain acceptanceweek 8Measured by the Emotional and Rational Disease Acceptance Questionnaire (ERDA)
Body awarenessweek 8Measured by the Scale of Body Connection (SBC)
Global Impressionweek 8Measured by the Patient Global Impression of Improvement Questionnaire (PGI-I)
Safetyweek 8All adverse events are recorded
Stress perceptionweek 8Measured by the Perceived Stress Questionnaire (PSQ-20)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026